Alphatec Holdings, Inc.
NASDAQ:ATECMedical - Devices
+$0.33 today
- Market cap
- $1.10B
- Beta
- 0.87
- P/E (TTM)
- -10.5
- EPS (TTM)
- -$0.81
Volume 2.80M
Average 3.21M
ATEC Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Alphatec Holdings, Inc.NASDAQ: ATEC
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development growth accelerates
Q1 FY2026 research & development of $17.56M rose 5.9% year over year, ahead of the -2.6% change in trailing-twelve-month research & development. Sequentially, it fell 22.7% from the prior quarter. Over 3 fiscal years it compounded at +20.1% a year.
Context
- Research & development amounted to 10.0% of revenue in FY2025, down 3.2 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +5.9% holds above the trailing-twelve-month pace of -2.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 76.27M USD
- Year-over-year change
- -5.5%
- 4-year CAGR
- +24.2%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 76.27M | -5.5% |
| FY2024 | 2024-12-31 | 80.72M | +15.1% |
| FY2023 | 2023-12-31 | 70.12M | +59.2% |
| FY2022 | 2022-12-31 | 44.03M | +37.5% |
| FY2021 | 2021-12-30 | 32.02M | — |
Research & Development vs competitors
How ATEC compares with its peers on the latest reported figures
- ATEC's LTM Mar 2026 research & development of $77.25M is the 5th highest of the 7 companies compared; the peer median is $141.28M.
- Its year-over-year change of -2.6% is the 4th highest of 7, against a peer median of -4.1%.
- Research & development amounts to 9.8% of revenue for ATEC, versus a peer median of 5.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.66B | +10.1% | +8.8% | 6.4% | |
| FY2025 | $346M | +0.9% | +0.1% | 5.6% | |
| LTM Jun 2026 | $184.82M | +30.3% | +36.3% | 5.9% | |
| LTM Mar 2026 | $97.75M | -13.6% | -0.7% | 5.9% | |
| LTM Mar 2026 | $77.25M | -2.6% | +20.1% | 9.8% | |
| LTM Mar 2026 | $61.4M | -16.9% | +5.2% | 7.4% | |
| LTM Mar 2026 | $2.09M | -9.0% | +31.9% | 1.7% | |
| Peer median (excluding ATEC) | $141.28M | -4.1% | +7.0% | 5.9% | |
Competitors are the stored peer set for ATEC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 243.21M | 350.87M | 482.26M | 611.56M | 764.16M |
| Cost of Revenue | 85.45M | 117.81M | 172.06M | 187.3M | 232.27M |
| Gross Profit | 157.76M | 233.06M | 310.2M | 424.26M | 531.89M |
| Gross Margin | 64.9% | 66.4% | 64.3% | 69.4% | 69.6% |
| Research & Development | 32.02M | 44.03M | 70.12M | 80.72M | 76.27M |
| Selling, General & Admin | 229.27M | 300.01M | 374.08M | 450.2M | 498.53M |
| Operating Expenses | 285.82M | 380.03M | 483.6M | 560.43M | 614.02M |
| Depreciation & Amortization | 30.17M | 43.93M | 59.68M | 83.32M | 82.56M |
| EBITDA | (106.88M) | (102.58M) | (110.59M) | (53.87M) | (39.7M) |
| EBITDA Margin | -43.9% | -29.2% | -22.9% | -8.8% | -5.2% |
| Operating Income | (128.06M) | (146.98M) | (173.4M) | (136.17M) | (82.13M) |
| Operating Margin | -52.7% | -41.9% | -36.0% | -22.3% | -10.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 7.11M | 5.51M | 16.64M | 24.88M | 21.14M |
| Other Income / Expenses | (16.11M) | (5.03M) | (13.52M) | (25.9M) | (61.28M) |
| Income Before Tax | (144.16M) | (152.01M) | (186.92M) | (162.07M) | (143.4M) |
| Pre-Tax Margin | -59.3% | -43.3% | -38.8% | -26.5% | -18.8% |
| Income Tax Expense | (1.13M) | (716K) | (277K) | 50K | (45K) |
| Net Income | (143.03M) | (151.29M) | (186.64M) | (162.12M) | (143.36M) |
| Net Margin | -58.8% | -43.1% | -38.7% | -26.5% | -18.8% |
| EPS (Basic) | (1.50) | (1.47) | (1.54) | (1.13) | (0.96) |
| EPS (Diluted) | (1.50) | (1.47) | (1.54) | (1.13) | (0.96) |
| Weighted Avg Shares | 96.2M | 103.37M | 121.24M | 142.95M | 150.06M |
| Weighted Avg Shares (Diluted) | 96.2M | 103.37M | 121.24M | 142.95M | 150.06M |
Alphatec Holdings, Inc.
NASDAQ:ATEC
Intrinsic Alpha fair value
Locked
Current Price
$7.06
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.